Friday, 19 April 2024
BioMarin Pharmaceutical Inc.
NASDAQ : BMRN
87.25 14 Oct 22 00:00 | Change: 2.15 | Open: 89.89 | High: 90.31 | Ask: 18.46 | Volume: 1,177,100 |
Change(%): 2.40 | Prev: 89.40 | Low: 87.13 | Bid: 18.10 | Avg vol: 0 |
09:37 | 17/3/18
Simply Wall St
BioMarin Pharmaceutical Inc's (NASDAQ:BMRN): BioMarin Pharmaceutical, Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.
more»
01:45 | 17/3/18
registrarjournal.com
BioMarin Pharmaceutical logo BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Jeffrey Robert Ajer sold 2,972 shares of BioMarin Pharmaceutical stock in a transaction on Friday, March 9th.
more»
01:11 | 17/3/18
Post Analyst
Las Vegas Sands Corp. (NYSE:LVS), with a trailing 12-month price-to-sales ratio of 4.53, is now among the bigger bargains in its industry.
more»
23:30 | 16/3/18
Wall Street Morning
Technical analysis of BioMarin Pharmaceutical Inc. (BMRN) stock includes the study of technical indicators and past trends.
more»
10:22 | 16/3/18
Frisco Fastball
Investors sentiment decreased to 1.13 in Q3 2017. Its down 0.13, from 1.26 in 2017Q2. It worsened, as 40 investors sold BMRN shares while 116 reduced holdings.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |